These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11548888)

  • 1. Usefulness of selective myocardial contrast echocardiography in percutaneous transluminal septal myocardial ablation: a case report.
    Okayama H; Sumimoto T; Morioka N; Yamamoto K; Kawada H
    Jpn Circ J; 2001 Sep; 65(9):842-4. PubMed ID: 11548888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous transluminal septal myocardial ablation: past, present, and future.
    Maekawa Y; Takamisawa I; Takano H; Takayama M
    J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T; Tsuchikane E; Tanaka N; Suzuki T
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
    Pfeiffer B; Rigopoulos A; Seggewiß H
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
    Faber L; Seggewiss H; Ziemssen P; Gleichmann U
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
    Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
    Faber L; Seggewiss H; Gleichmann U
    Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
    Pedone C; Vijayakumar M; Ligthart JM; Valgimigli M; Biagini E; De Jong N; Serruys PW; Ten Cate FJ
    Int J Cardiovasc Intervent; 2005; 7(3):134-7. PubMed ID: 16243734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Jensen MK; Havndrup O; Pecini R; Dalsgaard M; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Eur J Echocardiogr; 2010 Oct; 11(9):763-9. PubMed ID: 20472917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
    Arslan F; Akdim F; Ten Berg JM
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):488-492. PubMed ID: 32808736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
    Imori Y; Takano H; Kitamura M; Aoyama R; Sangen H; Kenta O; Matsuda J; Kubota Y; Tokita Y; Yamamoto T; Asai K; Takayama M; Shimizu W
    Heart Vessels; 2020 May; 35(5):647-654. PubMed ID: 31641886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Ziemssen P
    Cardiol Rev; 1999; 7(6):316-23. PubMed ID: 11208243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
    Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
    Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary muscles identified by myocardial contrast echocardiography in preparation for percutaneous transluminal septal myocardial ablation.
    Harada T; Ohtaki E; Sumiyoshi T
    Acta Cardiol; 2002 Feb; 57(1):25-7. PubMed ID: 11918131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
    J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous transluminal septal myocardial ablation combined with permanent dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a case report].
    Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Azuma A; Nakagawa M
    J Cardiol; 2000 Nov; 36(5):331-6. PubMed ID: 11107555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.